<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35785594</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-035X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of infection and public health</Title><ISOAbbreviation>J Infect Public Health</ISOAbbreviation></Journal><ArticleTitle>Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>856</StartPage><EndPage>869</EndPage><MedlinePgn>856-869</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2022.06.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1876-0341(22)00157-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several studies have reported prolonged symptoms especially neurological symptoms following acute infection in patients with COVID-19, known as long COVID-19. There are only few studies investigating this population and relatively less known, including nervous system involvement. A systematic review and meta-analysis of these studies are required to understanding the prevalence of persistent neurological manifestations after COVID-19.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To conduct a systematic review and meta-analysis on the persistent neurological manifestations in COVID-19 survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Authors conducted a literature search through PubMed and MedRxiv from January 1st, 2020 to October 2021 according to PRISMA guideline. Furthermore, the authors added additional sources by reviewing related references. Studies presenting the neurologic features of long COVID-19 patients in their data were included. Case reports and case series also included in this review. The quality of the studies was assessed based on the Oxford Centre for Evidence-Based Medicine guidelines. Selected studies were included in the meta-analysis of proportion and heterogeneity test.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">From 128 identified studies, 36 were eligible, with 9944 participants included. Most of the included studies had mean duration of follow-up after COVID-19 onset of less than 6 months. Fatigue was the most common (52.8%, 95%CI 19.9 - 84.4) symptoms of long COVID, followed by cognitive disorder (35.4%, 95%CI 2.1 - 81.7); paresthesia (33.3%, 95%CI 2.7 - 76.6); sleep disorder (32.9%, 95%CI 6.5 - 67.4); musculoskeletal pain (27.8%, 95%CI 12.7 - 46); and dizziness (26.4%, 95%CI 4.6 - 57.9).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neurological manifestations are prevalent and persisting in patients with long COVID. The duration of the symptoms are vary among literatures. However, the frequency are mostly observed during the first six months after the illness onset.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinzon</LastName><ForeName>Rizaldy Taslim</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Duta Wacana Christian University, Yogyakarta, Indonesia; Neurology Department, Bethesda Hospital, Yogyakarta, Indonesia. Electronic address: drpinzon17@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijaya</LastName><ForeName>Vincent Ongko</ForeName><Initials>VO</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Duta Wacana Christian University, Yogyakarta, Indonesia. Electronic address: vincent_wijaya007@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jody</LastName><ForeName>Abraham Al</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Duta Wacana Christian University, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunsio</LastName><ForeName>Patrick Nalla</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Duta Wacana Christian University, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buana</LastName><ForeName>Ranbebasa Bijak</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Duta Wacana Christian University, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect Public Health</MedlineTA><NlmUniqueID>101487384</NlmUniqueID><ISSNLinking>1876-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Manifestation</Keyword><Keyword MajorTopicYN="N">Neurology</Keyword></KeywordList><CoiStatement>Conflict of Interest Authors have no conflict of interest to disclose, including personal relationships, financial or otherwise.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>5</Day><Hour>10</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35785594</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pii">S1876-0341(22)00157-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic. World Health Organization (WHO);2020. Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Kang S., Peng W., Zhu Y., Lu S., Zhou M., Lin W., et al.  Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment. Int J Antimicrob Agents. 2020;55(5) &#x3008;&#x3009;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118423</ArticleId><ArticleId IdType="pubmed">32234465</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Fang Y.Y., Deng Y., Liu W., Wang M.F., Ma J.P., et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020;133(9):1025&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147277</ArticleId><ArticleId IdType="pubmed">32044814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.Y., Li X.L., Yan Z.R., Sun X.P., Han J., Zhang B.W. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord. 2020;13. De Felice FG, Tovar-Moll F, Moll J, Munoz DP, Ferreira ST. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 2020;43(6):355&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172664</ArticleId><ArticleId IdType="pubmed">32359765</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E.J., Chou S.H., Coles A.J., Menon D.K. Neurological implications of COVID-19 infections. Neurocrit Care. 2020;32(3):667&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188454</ArticleId><ArticleId IdType="pubmed">32346843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik I.J., Tyler K.L. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet. Facing up to long COVID. The Lancet. 2020;396(10266):1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokugamage A., Taylor S., Rayner C. Patients&#x2019; experiences of &#x201c;longcovid&#x201d; are missing from the NHS narrative [Internet]. the bmj opinion. 2020 [cited 2021 Apr 23]. Available from: https://blogs.bmj.com/bmj/2020/07/10/patients-experiences-of-longcovid-are-missing-from-the-nhsnarrative/.</Citation></Reference><Reference><Citation>Alwan N.A., Attree E., Blair J.M., Bogaert D., Bowen M.-A., Boyle J., et al. From doctors as patients: a manifesto for tackling persisting symptoms of covid-19. BMJ. 2020 15;370:m3565.</Citation><ArticleIdList><ArticleId IdType="pubmed">32933949</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E., Callard F., Stras L., Melville-Johannesson B., Pope R., Alwan NA. Why we need to keep using the patient made term &#x201c;Long Covid&#x201d; [Internet]. the bmj opinion. 2020 [cited 2021 Apr 23]. Available from: https://blogs.bmj.com/bmj/2020/10/01/why-we-need-to-keep-using-the-patient-madeterm-long-covid/.</Citation></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc Sci Med 1982. 2021 Jan;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 11:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188] [Internet]. National Institute for Health and Care Excellence; 2020 [cited 2021 Apr 23]. Available from: https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 1;5(11):1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F., Ye T., Sun P., Gui S., Liang B., Li L., et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19) Radiology. 2020;295(3):715&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n Casas C., Catal&#xe0; A., Carretero Hern&#xe1;ndez G., Rodr&#xed;guez-Jim&#xe9;nez P., Fern&#xe1;ndez-Nieto D., Rodr&#xed;guez-Villa, et al. Classification of the cutaneous manifestations of COVID-19: a rapidprospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267236</ArticleId><ArticleId IdType="pubmed">32348545</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A. Petticrew et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA- P) 2015 statement. Syst Rev. 2015;4(1) doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>OCEBM Levels of Evidence Working Group. The Oxford Levels of Evidence 2. Oxford: Oxford Centre for Evidence-Based Medicine (2011).</Citation></Reference><Reference><Citation>Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumpa F., Forde C., Manjaly J. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep. 2020;13(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7554505</ArticleId><ArticleId IdType="pubmed">33051251</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll E., Neumann H., Aguero&#x2010;Rosenfeld M., Lighter J., Czeisler B., Melmed K., et al. Post&#x2013;COVID&#x2010;19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020;61:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537028</ArticleId><ArticleId IdType="pubmed">32944946</ArticleId></ArticleIdList></Reference><Reference><Citation>Zito A., Alfonsi E., Franciotta D., Todisco M., Gastaldi M., Cotta Ramusino M., et al. COVID-19 and Guillain&#x2013;Barr&#xe9; syndrome: a case report and review of literature. Front Neurol. 2020:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471770</ArticleId><ArticleId IdType="pubmed">32973665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalagli A., Peiti G., Conti C., Penati R., Vavassori F., Taveggia G. Cranial nerves impairment in post-acute oropharyngeal dysphagia after COVID-19. Eur J Phys Rehabil Med. 2021;56(6)</Citation><ArticleIdList><ArticleId IdType="pubmed">32940446</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes&#x2010;Bueno J., Garc&#xed;a&#x2010;Trujillo L., Urbaneja P., Ciano&#x2010;Petersen N., Postigo&#x2010;Pozo M., Mart&#xed;nez&#x2010;Tom&#xe1;s C., et al. Miller&#x2010;Fisher syndrome after SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2020;27(9):1759&#x2013;1761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300794</ArticleId><ArticleId IdType="pubmed">32503084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilinc D., Pasch S., Doets A., Jacobs B., Vliet J., Garssen M. Guillain&#x2013;Barr&#xe9; syndrome after SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2020;27(9):1757&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323246</ArticleId><ArticleId IdType="pubmed">32533876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitry M., Collins L., Kazam J., Kaicker S., Kovanlikaya A. Parsonage-turner syndrome associated with SARS-CoV2 (COVID-19) infection. Clin Imaging. 2021;72:8&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7654330</ArticleId><ArticleId IdType="pubmed">33190028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bureau B., Obeidat A., Dhariwal M., Jha P. Peripheral neuropathy as a complication of SARS-Cov-2. Cureus. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673277</ArticleId><ArticleId IdType="pubmed">33214969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T., Sales C., Crewther S., Nguyen V., Karimi L. First Australian case of good recovery of a COVID-19 patient with severe neurological symptoms post prolonged hospitalization. Cureus. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7549849</ArticleId><ArticleId IdType="pubmed">33062489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan T., Rani B. A case of multisystem inflammatory syndrome Post-COVID-19 infection in an adult. Cureus. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7788052</ArticleId><ArticleId IdType="pubmed">33425537</ArticleId></ArticleIdList></Reference><Reference><Citation>Raahimi M., Kane A., Moore C., Alareed A. Late onset of Guillain-Barr&#xe9; syndrome following SARS-CoV-2 infection: part of &#x2018;long COVID-19 syndrome&#x2019;? BMJ Case Rep. 2021;14(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813388</ArticleId><ArticleId IdType="pubmed">33462068</ArticleId></ArticleIdList></Reference><Reference><Citation>Roushdy T., Hamid E. A case series of post COVID-19 mucormycosis&#x2014;a neurological prospective. Egypt J Neurol, Psychiatry Neurosurg. 2021;57:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8312207</ArticleId><ArticleId IdType="pubmed">34335016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dono F., Carrarini C., Russo M., De Angelis M., Anzellotti F., Onofrj M., et al. New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report. Neurol Sci. 2020;42(1):35&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7608104</ArticleId><ArticleId IdType="pubmed">33145624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D., Cambula G., Bacile I., Rizzo M., Galia M., Mangiapane P., et al. Long-term brain disorders in post covid-19 neurological syndrome (PCNS) patient. Brain Sci. 2021;11(4):454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8066611</ArticleId><ArticleId IdType="pubmed">33918426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar S.B.A., Haider M.A., Zia Z., Niazi M., Iqbal Q.Z. Clinical, radiological, and molecular findings of acute encephalitis in a COVID-19 patient: a rare case report. Cureus. 2020 25;12(9) doi: 10.7759/cureus.10650. PMID: 33133820; PMCID: PMC7586424.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10650</ArticleId><ArticleId IdType="pmc">PMC7586424</ArticleId><ArticleId IdType="pubmed">33133820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M., Kouda K., Mizoguchi T., Yokota Y., Hayashi K., Gon Y., et al. COVID-19 post-infectious encephalitis presenting with delirium as an initial manifestation. J Invest Med High Impact Case Rep. 2021;9 232470962110297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267028</ArticleId><ArticleId IdType="pubmed">34229469</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Goyal S., Comellas A. Post-acute COVID-19 functional movement disorder. SAGE Open Med Case Rep. 2021;9 2050313X2110393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366195</ArticleId><ArticleId IdType="pubmed">34408879</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte &#xc1;., Rivera-Izquierdo M., Guerrero-Fern&#xe1;ndez de Alba I., P&#xe9;rez-Contreras M., Fern&#xe1;ndez-Mart&#xed;nez N., Ruiz-Montero R., et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mezzeoui S., Aftiss F., Aabdi M., Bkiyar H., Housni B. Guillan barre syndrome in post Covid-19 infection in children. Ann Med Surg. 2021;67</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214813</ArticleId><ArticleId IdType="pubmed">34178315</ArticleId></ArticleIdList></Reference><Reference><Citation>Taribagil P., Creer D., Tahir H. &#x2018;Long COVID&#x2019; syndrome. BMJ Case Rep. 2021;14(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057566</ArticleId><ArticleId IdType="pubmed">33875508</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty K., Jadhav A., Jayanthakumar R., Jamwal S., Shanubhogue T., Reddy M., et al. Myoclonus-ataxia syndrome associated with COVID-19. J Mov Disord. 2021;14(2):153&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175811</ArticleId><ArticleId IdType="pubmed">33819422</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadan B., Shankar A., Rajakumar A., Subramanian S., Sathya A., Hakeem A., et al. Acute hemorrhagic leukoencephalitis in a COVID-19 patient&#x2014;a case report with literature review. Neuroradiology. 2021;63(5):653&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878029</ArticleId><ArticleId IdType="pubmed">33575849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, Zubair AS, Desai K., Abulaban A., Roy B. Guillain-Barr&#xe9; Syndrome as a Complication of COVID-19. Cureus. 2021 Jan 14;13(1):e12695. doi: 10.7759/cureus.12695. PMID: 33614303; PMCID: PMC7883582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883582</ArticleId><ArticleId IdType="pubmed">33614303</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrvini B., Prajapati D.P., Said M., Liu J., Srinivas S., Jayaraj S., et al. Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients. Int Forum Allergy Rhinol. 2021;11(8):1280&#x2013;1282. doi: 10.1002/alr.22802. Epub 2021 Apr 17. PMID: 33864717; PMCID: PMC8251222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22802</ArticleId><ArticleId IdType="pmc">PMC8251222</ArticleId><ArticleId IdType="pubmed">33864717</ArticleId></ArticleIdList></Reference><Reference><Citation>El Aidouni G., Touihar S., Merbouh M., Aabdi M., El Kaouini A., Bouabdallaoui A., et al. Guillain Barre syndrome as a complication of SARS-CoV-2 infection: a case report. Ann Med Surg (Lond) 2021;68 doi: 10.1016/j.amsu.2021.102672. Epub 2021 Aug 5. PMID: 34377452; PMCID: PMC8340561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102672</ArticleId><ArticleId IdType="pmc">PMC8340561</ArticleId><ArticleId IdType="pubmed">34377452</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y., Van Herck M., Delbressine J., Vaes A., Meys R., Machado F., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D., Holdsworth L., Jawad N., Gunasekera P., Morice A., Crooks M. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199(2):113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D., Bai F., Castoldi R., Barbanotti D., Falcinella C., Mul&#xe8; G., et al. Anxiety and depression symptoms after virological clearance of COVID&#x2010;19: a cross&#x2010;sectional study in Milan, Italy. J Med Virol. 2020;93(2):1175&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLOS ONE. 2020;15(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E., Clark J., Orban Z., Lim P., Szymanski A., Taylor C., et al. Persistent neurologic symptoms and cognitive dysfunction in non&#x2010;hospitalized Covid&#x2010;19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Polesel J., Marcuzzo A., Capriotti V., D&#x2019;Alessandro A. et al. Long COVID In Adults at 12 Months After Mild-to-Moderate SARS-CoV-2 Infection. medRxiv 2021.04.12.21255343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M., Hossain K., Saunders K., Uddin Z., Walton L., Raigangar V. et al. Prevalence of Long COVID symptoms in Bangladesh: A Prospective Inception Cohort Study of COVID-19 survivors. medRxiv 2021.07.03.21259626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A., Ara&#xfa;jo-Ameijeiras A., Fern&#xe1;ndez-Villar A., Crespo M., Poveda E. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. medRxiv 2021.08.05.21261634.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15. PMID: 34308300; PMCID: PMC8280690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLOS ONE. 2020;15(11) Availablefrom:https://doi.org/10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M., Go&#xeb;rtz Y.M., Houben-Wilke S., Machado F.V., Meys R., Delbressine J.M., et al. Severe fatigue in long COVID: web-based quantitative follow-up study in members of online long COVID support groups. J Med Internet Res. 2021;23(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases [Internet]. 2021 May 22 [cited 2021 Nov 20];53(10):737&#x2013;54. Available from: https://doi.org/10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zheng X.S., Shen X.R., et al. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020;9(1):1&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734137</ArticleId><ArticleId IdType="pubmed">33196399</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenz J.C.C., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhan H., Zhang F., et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302&#x2013;1310. e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., et al. Alterations in gut microbiota of patients with covid-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955. e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi N., Rezaei N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int. 2020;44(9):1792&#x2013;1797.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283672</ArticleId><ArticleId IdType="pubmed">32458561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong M., Zhang H., Cao X., et al. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect. 2020;148</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360950</ArticleId><ArticleId IdType="pubmed">32641174</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Zhao H., Song P., et al. Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A. J Infect Public Health. 2019;12(6):878&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102863</ArticleId><ArticleId IdType="pubmed">31202719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Yin Z., Xu J., Wang S., Liao T., Wang K., et al. Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China. J Infect Dis. 2021;224(9):1473&#x2013;1488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083630</ArticleId><ArticleId IdType="pubmed">33822106</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med. 2021;7:1132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R., Preez S., Eaton-Fitch N., et al. A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques. PLoS One. 2020;15(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192498</ArticleId><ArticleId IdType="pubmed">32353033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi S., Srivastava AK, Ray U., Tripathi PP. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? ACS Chemical Neuroscience [Internet]. 2020 Apr 29 [cited 2021 Nov 20];11(10):1379&#x2013;81. Available from: https://doi.org/10.1021/acschemneuro.0c00217.</Citation><ArticleIdList><ArticleId IdType="pubmed">32348111</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., et al. Cerebral micro-structural changes in COVID-19 patients &#x2013; An MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Tong T., Chew J., et al. Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci. 2019;13:1361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6971226</ArticleId><ArticleId IdType="pubmed">32009871</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R., Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive Impairment After COVID-19-A Review on Objective Test Data. Front Neurol. 2021;12:699582. Published 2021 Jul 29. doi:10.3389/fneur.2021.699582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19. JAMA Network Open [Internet]. 2021 May 26 [cited 2021 Nov 20];4(5):e2111417. Available from: https://doi.org/10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayed J., Bohn T. Adapted sickness behavior - why it is not enough to limit the COVID-19 spread? Brain Behav Immun. 2021;93:4&#x2013;5. doi: 10.1016/j.bbi.2020.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.028</ArticleId><ArticleId IdType="pmc">PMC7836998</ArticleId><ArticleId IdType="pubmed">33412256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>